3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Neoplasms
4
Pancreatic Neoplasms
2
Malnutrition
2
Rectal Neoplasms
1
Psychological Well-Being
1
Pancreatitis, Chronic
1
Ovarian Neoplasms
1
Motor Activity
1
Liver Neoplasms
1
Glucose Metabolism Disorders
1
Duodenal Neoplasms
1
Diabetes, Gestational
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Breast Neoplasms
1
Bile Duct Neoplasms
1
Ascites
1
Appendiceal Neoplasms
1
Interventions
Paclitaxel
35
Carboplatin
35
Bevacizumab
14
olaparib
13
niraparib
11
apatinib
11
Gemcitabine
10
liposomal doxorubicin
9
Hyperthermic Intraperitoneal Chemotherapy
9
Cisplatin
9
pembrolizumab
8
Cyclophosphamide
8
fludarabine
7
Etoposide
7
Topotecan
6
fluzoparib
5
Surveys and Questionnaires
5
Drug Therapy
5
Albumin-Bound Paclitaxel
5
anlotinib
4
Immunohistochemistry
4
Ifosfamide
4
Doxorubicin
4
Docetaxel
4
Cytoreduction Surgical Procedures
4
Taxes
3
Surgical Procedures, Operative
3
Poly(ADP-ribose) Polymerase Inhibitors
3
Neoadjuvant Therapy
3
Laparoscopy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Ovarian Neoplasms
×
Nutritional Status
×
Clear all
NCT05305820
2024-03-21
PANO
Dublin City University
Phase NA
Unknown
36 enrolled